These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15345871)

  • 1. Control of Japanese encephalitis in India: a reality.
    Kabilan L
    Indian J Pediatr; 2004 Aug; 71(8):707-12. PubMed ID: 15345871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis vaccine: need of the hour in endemic states of India.
    Verma R
    Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
    Muniaraj M; Rajamannar V
    Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.
    Saxena V; Dhole TN
    J Biosci; 2008 Nov; 33(4):505-14. PubMed ID: 19208976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
    Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
    Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and control of Japanese encephalitis.
    Igarashi A
    World Health Stat Q; 1992; 45(2-3):299-305. PubMed ID: 1334301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage of Japanese encephalitis routine vaccination among children in central India.
    Tandale BV; Deshmukh PS; Narang R; Qazi MS; Padmaja GV; Deshmukh PR; Raut AV; Narlawar UW; Jha PK; Rajderkar SS;
    J Med Virol; 2023 Jan; 95(1):e28155. PubMed ID: 36114690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Japanese encephalitis vaccination among children in central India.
    Tandale BV; Khude PM; Deshmukh PS; Narang R; Qazi MS; Padmaja GV; Jain M; Jain D; Guduru VK; Deshmukh PR; Raut AV; Narlawar UW; Jha PK; Rajderkar SS;
    J Med Virol; 2023 Jan; 95(1):e28399. PubMed ID: 36512338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of effectiveness of Japanese encephalitis vaccination in West Bengal, India using sample positivity rate as an alternate measure.
    Chakraborty D; Banerjee S; Maji D; Dey TK; Vaitheeswaran K; Mondal P; Biswas P; Debnath F; Chatterjee P
    J Vector Borne Dis; 2021; 58(3):199-205. PubMed ID: 35170456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
    Moore SM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adults in Northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study.
    Zhang X; Jin N; Tu A; Dong M; Shi T; Ren X; Liu S; Zhao X; Liu J; Wu Z; Li Y; Wu D; Wang H; Wang H; Hu Y; Zhang B; Wang W; Meng L
    J Med Virol; 2023 May; 95(5):e28782. PubMed ID: 37212323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis in India: an overview.
    Kabilan L; Rajendran R; Arunachalam N; Ramesh S; Srinivasan S; Samuel PP; Dash AP
    Indian J Pediatr; 2004 Jul; 71(7):609-15. PubMed ID: 15280610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis in Malaysia: An overview and timeline.
    Kumar K; Arshad SS; Selvarajah GT; Abu J; Toung OP; Abba Y; Yasmin AR; Bande F; Sharma R; Ong BL
    Acta Trop; 2018 Sep; 185():219-229. PubMed ID: 29856986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
    Appaiahgari MB; Vrati S
    Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of Japanese encephalitis vaccination programme in Uttar Pradesh, India: a cost-benefit study.
    Singh K
    J Vector Borne Dis; 2014 Mar; 51(1):47-52. PubMed ID: 24717202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.